The lack of exon 19 and 21 EGFR mutations and low frequency of K-RAS and PI3K mutations present in our panel in consistent with the molecular characteristics observed in HNSCC patients [27], [28]. This evidence concerns the gene KRAS and head and neck squamous cell carcinoma.